Biotech’s Blind Spot: Why Verifiable Data Integrity Is Now a Strategic Imperative
Biotech is no stranger to innovation—it’s built into its DNA. Today, the industry stands at a transformative crossroads: AI is accelerating drug discovery pipelines, decentralized trials are reshaping patient access, and gene therapies are redefining what personalized medicine can achieve. In a field driven by molecules, models, and milestone approvals, the pace of progress has […]
Biotech’s Blind Spot: Why Verifiable Data Integrity Is Now a Strategic Imperative Read More »